Investors Alert: Class Action Against Veritone, Inc. Due to Alleged Financial Misrepresentation

Overview of the Case

Levi & Korsinsky LLP has issued an important reminder regarding a pending class action lawsuit against Veritone, Inc. (NASDAQ: VERI). Investors who purchased shares between October 14, 2025, and April 14, 2026, may be affected by this lawsuit if they endured financial losses due to alleged misrepresentation of the company's financial data.

Background of the Allegations

According to the lawsuit, Veritone allegedly incorporated inaccurate financial results from its Q3 2025 earnings into an October 2025 prospectus filed with the SEC. Under Section 10(b) of the Securities Exchange Act of 1934 and SEC Rule 10b-5, making untrue statements of material fact or omitting necessary information is prohibited. As a result, the lawsuit claims that this misreporting may have opened the company to liabilities associated with securities fraud.

Financial Misrepresentation Details

The allegations highlight several misstatements according to the prospectus filed on October 16, 2025. Veritone claimed Q3 2025 revenue figures of between $28.5 million and $28.7 million, an increase of 30.5% from the previous year. However, the lawsuit asserts these numbers were overstated by approximately $2.2 million due to erroneous revenue recognition principles under ASC 606. The misleading financial data purportedly discounted important facts about the company’s operations, which could have influenced investors' decisions.

Key issues include:

- Revenue figures were inflated by about 8% based on the alleged misclassification of revenue and costs involved in transactions where Veritone functioned as an agent.
- Accounts receivable was overstated by $0.9 million, misleading shareholders regarding the company’s financial health.
- Material weaknesses in internal controls were characterized in a way that the lawsuit claims did not reflect the reality of the situation.

Impact on Investors

As a result of these inaccuracies, Veritone secured a favorable liquidity position through two equity offerings that occurred during the class period. Investors who bought shares based on the misleading information might have suffered significant financial losses when the true financial situation was revealed. On April 14, 2026, the company formally admitted that its Q3 2025 financial statements should no longer be considered reliable.

In light of this, Joseph E. Levi, Esq., noted: "The Private Securities Litigation Reform Act (PSLRA) provides critical protections for investors who suffer from alleged securities violations. When offering documents contain faulty financial statements, those who purchased the securities deserve a thorough examination of the circumstances surrounding the issuance."

Guidance for Affected Investors

Investors impacted by the proceedings can take action now. Those who purchased VERI stock within the specified timeframe are encouraged to gather relevant documentation, including brokerage records detailing purchase dates, quantities, and prices paid. Contacting Levi & Korsinsky for a free evaluation can provide insights into possible avenues for recovery. Note that participating in the class action will entail no upfront costs. The firm operates on a contingency basis, ensuring individuals are not burdened with fees until a recovery is made.

Class Action Participation

Motions for lead plaintiffs must be filed by July 20, 2026, and being designated as a lead plaintiff grants the investor overseeing responsibility for the case. Thus, individuals with the largest documented losses typically fill this role. It’s important to realize that having sold shares does not disqualify a requester from participation in recovery, as eligibility rests upon purchase dates rather than current ownership status.

In summary, the allegations against Veritone underscore the necessity for transparency and accuracy in financial reporting. As this case progresses, affected investors must remain informed and proactive in navigating both the litigation and their individual recovery options.

For further assistance, you can reach out to Joseph E. Levi, Esq., at [email protected] or by phone at (212) 363-7500.